溃疡性结肠炎
单克隆抗体
医学
单克隆
抗体
免疫学
内科学
疾病
作者
Bruce E. Sands,Brian G. Feagan,Laurent Peyrin‐Biroulet,Silvio Danese,David T. Rubin,Olivier Laurent,Allison Luo,Deanna D. Nguyen,Jiandong Lu,Mark Yen,Jarosław Leszczyszyn,Radosław Kempiński,Dermot McGovern,Christopher Ma,Timothy E. Ritter,Stephan Targan
标识
DOI:10.1056/nejmoa2314076
摘要
Tulisokibart is a tumor necrosis factor-like cytokine 1A (TL1A) monoclonal antibody in development for the treatment of moderately to severely active ulcerative colitis. A genetic-based diagnostic test was designed to identify patients with an increased likelihood of response.
科研通智能强力驱动
Strongly Powered by AbleSci AI